Soligenix, Inc. (SNGX)


+0.00 (+0.51%)
Symbol SNGX
Price $0.5357
Beta 1.673
Volume Avg. 0.13M
Market Cap 5.272M
Shares () -
52 Week Range 0.42-10.95
1y Target Est -
DCF Unlevered SNGX DCF ->
DCF Levered SNGX LDCF ->
ROE -4558.46% Strong Sell
ROA -80.31% Strong Sell
Operating Margin -
Debt / Equity 54.02% Buy
P/E -0.21 Neutral
P/B 0.67 Buy


Consensus EPS

Upgrades & Downgrades

Latest SNGX news

Dr. Christopher J. Schaber Ph.D.
NASDAQ Capital Market

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase I/II clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.